commercialisation

Sales & Marketing

Executing established pharma brand strategy: Key considerati...

As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands

R&D

The time is right for a grand resurgence of commercial clini...

In the dark days of 2020, amid the global race for a COVID-19 vaccine, the UK showcased its world-class expertise in medical research.

R&D

Building a regenerative medicine industry: Lessons from Nort...

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.

Digital

Pharma's AI is missing the "Why”

Artificial intelligence (AI) is reshaping the pharmaceutical industry, driving advances from drug discovery and clinical trial acceleration to manufacturing optimisation and commercialisati

R&D

The UK can’t just be a life sciences lab – we need manufactu...

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.

Digital

Unlocking AI's potential: Transforming healthcare commercial...

As the race to deliver personalised engagement at scale gains pace, artificial intelligence (AI) has become a critical differentiator for pharma companies.